Matthew Shea
Stock Analyst at Needham
(2.04)
# 2,983
Out of 4,581 analysts
37
Total ratings
52%
Success rate
1.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Shea
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TOI The Oncology Institute | Reiterated: Buy | $7 | $4.77 | +46.75% | 8 | Jul 7, 2026 | |
| ASTH Astrana Health | Rated: Buy | $30 → $41 | $36.51 | +12.30% | 3 | May 8, 2026 | |
| EVH Evolent Health | Reiterated: Buy | $4 → $5 | $3.30 | +51.52% | 11 | May 7, 2026 | |
| AGL agilon health | Reiterated: Hold | n/a | $92.66 | - | 8 | May 7, 2026 | |
| PRVA Privia Health Group | Reiterated: Buy | $30 | $24.12 | +24.38% | 7 | May 7, 2026 |
The Oncology Institute
Jul 7, 2026
Reiterated: Buy
Price Target: $7
Current: $4.77
Upside: +46.75%
Astrana Health
May 8, 2026
Rated: Buy
Price Target: $30 → $41
Current: $36.51
Upside: +12.30%
Evolent Health
May 7, 2026
Reiterated: Buy
Price Target: $4 → $5
Current: $3.30
Upside: +51.52%
agilon health
May 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $92.66
Upside: -
Privia Health Group
May 7, 2026
Reiterated: Buy
Price Target: $30
Current: $24.12
Upside: +24.38%